08:30 AM – 12:00 PM
Robyn L. Birdwell, MD, and Homer Aquino Macapinlac, MD
This session has sixteen sections. First is Session Introduction and Overview, while the second is Molecular Pathways That Define Breast Cancer Subtypes. The third section is Molecular Breast Imaging for Breast Cancer Screening in Women with Mammographically Dense Breasts: Proof of Concept. The fourth one is Breast-specific Gamma Imaging (BSGI) Compared to Mammography and Ultrasound in Patients Undergoing Diagnostic Breast Examinations. Fifth section is Role of PET/CT SUV in the Evaluation of Response to Neoadjuvant Therapy in IBC Patients, while the sixth is Comparative Effectiveness of Positron Emission Mammography and MRI for Presurgical Planning of the Ipsilateral Breast in Women with Breast Cancer. The seventh section is MR Spectroscopy of the Breast: A Role in Clinical Diagnosis and Development of New Imaging Technologies, while the eighth is Sensitivity and Specificity of Three Dimensional 1H Magnetic Resonance Spectroscopic Imaging (3D-MRSI) in Differentiation of Benign and Malignant Breast Lesions at 3 Tesla.
The section number nine is Evaluation of Responses to Neoadjuvant Chemotherapy in Patients with Breast Cancer Using MR Spectroscopy, while the tenth is T1-weighted MRI, Diffusion MRI, and 1H-MRS in Breast Cancer Patients before and after Neo-adjuvant Chemotherapy at 7 Tesla. The eleventh section is Overview of Molecular Imaging and Breast Imaging Applications. The section number twelve is Effect of Breast Density and b-value on Diffusion-weighted MRI of the Breast, while thirteenth is The Role of DWI in Evaluating Residual Breast Cancer after Neoadjuvant Chemotherapy: Comparison of 3T and 1.5T. The fourteenth section is Three-component Molecular Composition Map of Breast Distinguishes Abnormal Findings in Women. Fifteenth is Comparison of Positron Emission Mammography (PEM), Whole Body PET, and PET/CT in Breast Cancer Surgical Planning, and the sixteenth section is Panel Discussion: Future of Breast Molecular Imaging.